Scroll to next section

Press releases
View Concorde News Page

Scroll to next section
Universal Technical Institute Reports Fiscal Year 2023 Second Quarter Results

PHOENIX, May 9, 2023 /PRNewswire/ -- Universal Technical Institute, Inc. (NYSE: UTI), a leading workforce solutions provider of transportation, skilled trades and healthcare education programs, reported financial results for the fiscal 2023 second quarter ended March 31, 2023. Universal Technical Institute, Inc. operates in two reportable segments, Universal Technical Institute (UTI) and Concorde Career Colleges (Concorde), and together with its segments and subsidiaries is referred to as the "Company", "we," "us" or "our."

  • Revenue was $163.8 million with UTI increasing 5.4% versus the prior year period and Concorde contributing $56.3 million
  • Net income of $3.5 million, adjusted net income* of $6.3 million, and adjusted EBITDA* of $19.2 million.
  • Total new student starts of 4,626 with UTI increasing 4.4% versus the prior year period and 2,252 contributed by Concorde.
  • The Company reiterates its full year, fiscal 2023 guidance across all key metrics.
  • The Company's current year results include Concorde for the four months ended March 31, 2023, reflecting the December 1, 2022 closing date of the acquisition. Total company year-over-year comparisons are shown on an "as-reported basis," consistent with the Company's previously provided fiscal 2023 guidance.

"Our second quarter performance reflects our continued execution on reaching the fullest potential of our growth and diversification strategy," said Jerome Grant, CEO of Universal Technical Institute, Inc. "We delivered top- and bottom-line results that exceeded our expectations, aided by the first full quarter of financial contribution from Concorde. Further, we strengthened our divisional operating model and overall leadership capabilities by appointing higher education veteran Tracy Lorenz as President of UTI, and appointing Trinity Health's President and CEO, Michael Slubowski, to our board of directors. I am proud of the progress we have made with building out the infrastructure for our combined company.

"As we enter the second half of fiscal 2023, we remain focused on our key growth drivers for the UTI and Concorde segments. Within UTI, we will continue working to scale enrollment growth at our newest campuses in Austin, Texas and Miramar, Florida. We also remain underway with launching 14 new programs across nine UTI campuses, with the first new program launches currently on track for July. For Concorde, we will work to maintain the smooth progress we have made with integration, initially focusing on meeting public company requirements while facilitating a seamless student and staff experience, and also continuing efforts to launch three new dental hygiene programs in fiscal 2024. We look forward to further leveraging the benefits of our diversified business model as we support strong student outcomes across a growing, in-demand range of fields."

Financial Results for the Three-Month Period Ended March 31, 2023 Compared to 2022

  • Revenues increased 60.5% to $163.8 million compared to $102.1 million primarily due to the $56.3 million addition for the Concorde acquisition.
  • Operating expenses rose by 59.9% to $157.9 million, compared to $98.7 million. The acquisition of Concorde contributed $50.1 million of the increase. The remainder was driven primarily by the incremental cost of delivery associated with UTI new campus and program rollouts in the prior year, and both one-time and ongoing investments in support of our growth and diversification strategy.
  • Operating income was $5.9 million compared to $3.4 million.
  • Net income was $3.5 million compared to $7.4 million. Adjusted net income* was $6.3 million compared to $6.4 million.
  • Basic and diluted earnings per share (EPS) were $0.04 compared to $0.11.
  • Adjusted EBITDA* was $19.2 million compared to $12.6 million.

UTI

  • UTI had revenues of $107.6 million, a 5.4% increase from the prior year quarter revenues of $102.1 million driven primarily by the new campuses and programs launched in the prior year, and overall higher revenue per student, partially offset by lower average undergraduate full-time active students.
  • Operating expenses for UTI were $94.5 million, compared to $86.5 million. The increase was primarily due to higher compensation related and other expenses incurred during the current year due to the new campuses and welding programs launched in the prior year, along with costs for incremental advertising and admissions resources to support growth objectives for the segment.
  • Adjusted EBITDA* was $20.7 million compared to $21.5 million.
  • New student starts increased from prior year by 4.4%, while average undergraduate full-time active students decreased 3.0%.

Concorde

  • Revenues of $56.3 million.
  • Operating expenses were $50.1 million.
  • Adjusted EBITDA* was $8.4 million.
  • New student starts of 2,252 and 7,808 average undergraduate full-time active students.

*See "Use of Non-GAAP Financial Information" below.

"With our financial and operational execution during the quarter, we are entering the second half of fiscal 2023 on solid footing," said Troy Anderson, CFO of Universal Technical Institute. "Our second quarter revenue and profitability performance reflect the benefits of Concorde's contribution and the UTI fiscal 2022 new campus and program launches. We continue to reiterate our fiscal 2023 guidance, however, the anticipated phasing of our revenue and profitability throughout the year has shifted favorably relative to our initial expectations as a result of our strong first half results. Additionally, while we expect overall new student starts will be within our previous guidance range, we now see UTI starts at the lower end of their previously expected range, or approximately 8% year over year growth, and Concorde starts at the higher of their previously expected range. We continue to focus on execution across both segments of our business, along with further development of their respective strategic roadmaps."

Balance Sheet and Liquidity

At March 31, 2023, the Company's total available cash liquidity was $120.6 million, with an additional $8.2 million available from its revolving credit facility. In March 2023, the Company purchased the three primary buildings and associated land at its Orlando, Florida campus for $26.2 million. The purchase was completed using proceeds from its revolving credit facility that were drawn down in the previous quarter. Excluding the Orlando campus purchase, capital expenditures for the quarter and year total $4.2 million and $11.0 million, respectively, with the primary drivers being the completion of the UTI Austin and Miramar campus buildouts, as well as UTI and Concorde program expansions.

Financial Results for the Six-Month Period Ended March 31, 2023 Compared to 2022

  • Revenues increased 37.0% to $283.8 million compared to $207.2 million primarily due to the $70.7 million addition for the Concorde acquisition.
  • Operating expenses rose by 43.8% to $273.4 million, compared to $190.2 million. The acquisition of Concorde contributed $65.2 million. The remainder of the increase was primarily driven by the incremental cost of delivery associated with UTI new campus and program rollouts in the prior year, and both one-time and ongoing investments in support of our growth and diversification strategy.
  • Operating income was $10.4 million compared to $17.0 million.
  • Net income was $6.1 million compared to $22.2 million. Adjusted net income* was $11.7 million compared to $21.8 million.
  • Basic and diluted earnings per share (EPS) were $0.07 compared to $0.36.
  • Adjusted EBITDA* was $33.6 million compared to $33.2 million.

UTI

  • UTI had revenues of $213.1 million, a 2.9% increase from the prior year quarter revenues of $207.2 million driven primarily by the new campuses and programs launched in the prior year and overall higher revenue per student, partially offset by lower average undergraduate full-time active students.
  • Operating expenses for UTI were $183.5 million, compared to $168.4 million. The increase was primarily due to higher compensation related and other expenses incurred during the current year due to the new campuses and welding programs launched in the prior year, along with costs for incremental advertising and admissions resources to support growth objectives for the segment.
  • Adjusted EBITDA* was $44.0 million compared to $50.2 million.
  • New student starts increased 2.4% compared to the prior year, while average undergraduate full-time active students decreased 2.3%.

Concorde (for the four-month period beginning December 2022 and ended March 2023)

  • Revenues of $70.7 million. Of note, due to seasonality and phasing of clinical programs, December is one of the lowest revenue months of the year.
  • Operating expenses were $65.2 million.
  • Adjusted EBITDA* was $8.3 million.
  • New student starts of 2,573 and 7,773 average undergraduate full-time active students.

*See "Use of Non-GAAP Financial Information" below.

Student Metrics



Three Months Ended March 31, 2023



Three Months Ended March 31, 2022


UTI


Concorde


Total



UTI


Concorde


Total

Total new student starts

2,374


2,252


4,626



2,275



2,275

Average undergraduate full-time active students

12,516


7,808


20,324



12,903



12,903

End of period undergraduate full-time active students

12,104


7,708


19,812



12,466



12,466


Six Months Ended March 31, 2023



Six Months Ended March 31, 2022


UTI


Concorde


Total



UTI


Concorde


Total

Total new student starts

4,348


2,573


6,921



4,247



4,247

Average undergraduate full-time active students

13,014


7,773


20,787



13,316



13,316

End of period undergraduate full-time active students

12,104


7,708


19,812



12,466



12,466














For the Company's most recent investor presentation and quarterly financial supplement, please see its investor relations website at https://investor.uti.edu.

Conference Call

Management will hold a conference call to discuss the financial results for the fiscal 2023 second quarter ended March 31, 2023, on Tuesday, May 9, 2023, at 4:30 p.m. ET.

To participate in the live call, investors are invited to dial (844) 881-0138 (domestic) or (412) 317-6790 (international). A live webcast of the call will be available via the Universal Technical Institute, Inc. investor relations website at https://investor.uti.edu. Please go to the website at least 10 minutes early to register, download and install any necessary audio software. The conference call webcast will be archived for fourteen days at https://investor.uti.edu. Alternatively, the telephone replay can be accessed through May 22, 2023, by dialing (877) 344-7529 (domestic) or (412) 317-0088 (international) and entering passcode 3024812.

Use of Non-GAAP Financial Information

In addition to disclosing financial results that are determined in accordance with U.S. generally accepted accounting principles ("GAAP"), the Company also discloses certain non-GAAP financial information in this press release and may similarly disclose non-GAAP financial information on the related conference call. These financial measures are not recognized measures under GAAP and are not intended to be and should not be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP.  The Company discloses these non-GAAP financial measures because it believes that they provide investors an additional analytical tool to clarify its results of operations and identify underlying trends. Additionally, the Company believes that these measures may also help investors compare its performance on a consistent basis across time periods. Additional details on our non-GAAP measures and the tables reconciling these measures to the most directly comparable GAAP measure are provided below.

Adjusted EBITDA

For fiscal 2022, the Company defined adjusted EBITDA as net income (loss) before interest expense, interest income, income taxes, depreciation and amortization, adjusted for items not considered as part of the Company's normal recurring operations. Starting in fiscal 2023, the Company defines adjusted EBITDA as net income (loss) before interest expense, interest income, income taxes, depreciation and amortization, adjusted for stock-based compensation expense and items not considered normal recurring operations.  Prior year amounts have been restated to include stock-based compensation expense.

Adjusted Free Cash Flow

The Company defines adjusted free cash flow as net cash provided by (used in) operating activities less capital expenditures, adjusted for items not considered normal recurring operations.

Adjusted Net Income (Loss)

The Company defines adjusted net income (loss) as net income (loss), adjusted for items that affect trends in underlying performance from year to year and are not considered normal recurring operations, including the income tax effect on the adjustments utilizing the effective tax rate.     

We disclose any campus adjustments as direct costs (net of any corporate allocations). Management utilizes adjusted figures as performance measures internally for operating decisions, strategic planning, annual budgeting and forecasting.  For the periods presented, this includes acquisition-related costs for both announced and potential acquisitions, integration costs for completed acquisitions, costs related to the purchase of our campuses, impairment charges related to intangible assets, start-up costs associated with the Austin, TX and Miramar, FL campus openings, lease accounting adjustments resulting from the purchase of our Lisle, Illinois campus and our campus consolidation efforts, the income tax benefit recorded as a result of the CARES Act, and severance expenses due to the CEO transition. To obtain a complete understanding of our performance, these measures should be examined in connection with net income (loss) and net cash provided by (used in) operating activities, determined in accordance with GAAP, as presented in the financial statements and notes thereto included in the annual and quarterly filings with the Securities and Exchange Commission ("SEC").  Because the items excluded from these non-GAAP measures are significant components in understanding and assessing our financial performance under GAAP, these measures should not be considered to be an alternative to net income (loss) or net cash provided by (used in) operating activities as a measure of our operating performance or liquidity.  Exclusion of items in the non-GAAP presentation should not be construed as an inference that these items are unusual, infrequent or non-recurring. Other companies, including other companies in the education industry, may define and calculate non-GAAP financial measures differently than we do, limiting their usefulness as a comparative measure across similarly titled performance measures presented by other companies. A reconciliation of the historical non-GAAP financial measures to the most directly comparable GAAP measures is provided below and investors are encouraged to review the reconciliations.

Forward Looking Statements

All statements contained in this press release and the related conference call, other than statements of historical fact, are "forward-looking" statements within the meaning of the safe harbor from civil liability provided for such statements by the Private Securities Litigation Reform Act of 1995 (set forth in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended). These forward-looking statements which address our expected future business and financial performance, may contain words such as "goal," "target," "future," "estimate," "expect," "anticipate," "intend," "plan," "believe," "seek," "project," "may," "should," "will," the negative form of these expressions or similar expressions. Examples of forward-looking statements include, among others, statements regarding (1) the Company's expectation that it will meet its fiscal year 2023 guidance for new student start growth (decline), revenue growth, Adjusted net income, Adjusted EBITDA and Adjusted Free Cash Flow; (2) expectation that it will continue to expand its value proposition and build a business that can grow in low-to-mid single digits with potential upside, regardless of the economic environment; (3) the Company's expectation that it will succeed in new campus launches next year; and (4) the Company's expectation of the successful integration of the Concorde acquisition. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on the Company's current beliefs, expectations and assumptions regarding the future of its business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could affect our actual results include, among other things, impacts related to the COVID-19 pandemic, changes to federal and state educational funding, changes to regulations or agency interpretation of such regulations affecting the for-profit education industry, possible failure or inability to obtain regulatory consents and certifications for new or modified campuses or instruction, potential increased competition, changes in demand for the programs we offer, increased investment in management and capital resources, failure to comply with the restrictive covenants and our ability to pay the amounts when due under the Credit Agreement with Fifth Third Bank, National Association, the effectiveness of our student recruiting, advertising and promotional efforts, changes to interest rates and unemployment, general economic and political conditions, the adoption of new accounting standards, and other risks that are described from time to time in our public filings. Further information on these and other potential factors that could affect the financial results or condition may be found in the company's filings with the SEC.  Any forward-looking statements made by us in this press release and the related conference call are based only on information currently available to us and speak only as of the date on which it is made.  We expressly disclaim any obligation to publicly update any forward-looking statements, whether written or oral, that may be made from time to time, whether as a result of new information, future developments, changes in expectations, any changes in events, conditions or circumstances, or otherwise.

Social Media Disclosure

Universal Technical Institute, Inc uses its websites (https://www.uti.edu/, https://concorde.edu, and https://investor.uti.edu/) and LinkedIn pages (https://www.linkedin.com/school/universal-technical-institute/ and https://www.linkedin.com/school/concorde-career-colleges/) as channels of distribution of information about its programs, its planned financial and other announcements, its attendance at upcoming investor and industry conferences, and other matters. Such information may be deemed material information, and the Company may use these channels to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor the company's website and its social media accounts in addition to following the company's press releases, SEC filings, public conference calls, and webcasts.

About Universal Technical Institute, Inc.

Universal Technical Institute, Inc. (NYSE: UTI) was founded in 1965 and is a leading workforce solutions provider of transportation, skilled trades and healthcare education programs, whose mission is to serve students, partners, and communities by providing quality education and support services for in-demand careers across a number of highly-skilled fields. The Company is comprised of two divisions: Universal Technical Institute ("UTI") and Concorde Career Colleges ("Concorde"). UTI operates 16 campuses located in 9 states and offers a wide range of transportation and skilled trades technical training programs under brands such as UTI, MIAT College of Technology, Motorcycle Mechanics Institute, Marine Mechanics Institute and NASCAR Technical Institute. Concorde operates across 17 campuses in 8 states, offering programs in the Allied Health, Dental, Nursing, Patient Care and Diagnostic fields. For more information, visit www.uti.edu or www.concorde.edu, or visit us on LinkedIn at @UniversalTechnicalInstitute and @Concorde Career Colleges or on Twitter @news_UTI or @ConcordeCareer.

Company Contact:
Troy R. Anderson
Chief Financial Officer
Universal Technical Institute, Inc.
(623) 445-9365

Media Contact:
Mark Brenner
Vice President, Corporate Affairs & Communications
Universal Technical Institute, Inc.
(623) 445-0872

Investor Relations Contact:
Matt Glover or Jackie Keshner
Gateway Group, Inc.
(949) 574-3860
UTI@gatewayir.com

(Tables Follow)

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

(Unaudited)



Three Months Ended March 31,


Six Months Ended March 31,


2023


2022


2023


2022

Revenues

$           163,820


$           102,086


$           283,824


$          207,161

Operating expenses:








Educational services and facilities

86,930


49,209


148,338


97,110

Selling, general and administrative

70,941


49,500


125,089


93,096

  Total operating expenses

157,871


98,709


273,427


190,206

Income from operations

5,949


3,377


10,397


16,955

Other (expense) income:








Interest income

1,805


8


2,628


20

Interest expense

(2,637)


(466)


(4,060)


(699)

Other income, net

126


(163)


451


(45)

  Total other expense, net

(706)


(621)


(981)


(724)

Income before income taxes

5,243


2,756


9,416


16,231

Income tax (expense) benefit

(1,763)


4,598


(3,288)


5,945

Net income

3,480


7,354


$               6,128


$            22,176

Preferred stock dividends

(1,251)


(1,294)


(2,528)


(2,617)

Income available for distribution

2,229


6,060


$               3,600


$            19,559

Income allocated to participating securities

(833)


(2,359)


$              (1,348)


$             (7,622)

Net income available to common shareholders

$               1,396


$               3,701


$               2,252


$            11,937









Earnings per share:








Net income per share - basic

$                 0.04


$                 0.11


$                 0.07


$                0.36

Net income per share - diluted

$                 0.04


$                 0.11


$                 0.07


$                0.36









Weighted average number of shares outstanding:







Basic

33,999


32,992


33,901


32,920

Diluted

34,553


33,436


34,477


33,393

 

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except par value and per share amounts)

(Unaudited)



March 31, 2023


September 30, 2022

Assets


Cash and cash equivalents

$                    120,579


$                       66,452

Restricted cash

4,013


3,544

Held-to-maturity investments


28,918

Receivables, net

25,435


16,450

Notes receivable, current portion

5,954


5,641

Prepaid expenses

9,883


6,139

Other current assets

8,742


8,809

   Total current assets

174,606


135,953

Property and equipment, net

262,544


214,292

Goodwill

28,459


16,859

Intangible assets, net

19,322


14,215

Notes receivable, less current portion

30,497


30,231

Right-of-use assets for operating leases

182,958


132,038

Deferred tax asset, net

5,345


3,365

Other assets

8,984


5,958

   Total assets

$                     712,715


$                     552,911

Liabilities and Shareholders' Equity




Accounts payable and accrued expenses

$                       62,435


$                       66,680

Deferred revenue

64,814


54,223

Operating lease liability, current portion

21,233


12,959

Long-term debt, current portion

2,319


1,115

Other current liabilities

3,741


2,745

   Total current liabilities

154,542


137,722

Operating lease liability

171,704


129,302

Long-term debt

160,825


66,423

Other liabilities

4,777


4,067

   Total liabilities

491,848


337,514

Commitments and contingencies




Shareholders' equity:




Common stock, $0.0001 par value, 100,000 shares authorized, 34,149 and 33,857 shares issued

3


3

Preferred stock, $0.0001 par value, 10,000 shares authorized; 676 shares of Series A Convertible Preferred Stock issued and outstanding, liquidation preference of $100 per share


Paid-in capital - common

150,906


148,372

Paid-in capital - preferred

66,481


66,481

Treasury stock, at cost, 82 shares

(365)


(365)

Retained earnings (deficit)

2,293


(1,307)

   Accumulated other comprehensive income

1,549


2,213

   Total shareholders' equity

220,867


215,397

   Total liabilities and shareholders' equity

$                    712,715


$                    552,91

 

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)




Six Months Ended March 31,



2023


2022

Cash flows from operating activities:





Net income


$                   6,128


$                 22,176

Adjustments to reconcile net income to net cash (used in) provided by operating activities:





Depreciation and amortization


11,994


7,563

Amortization of right-of-use assets for operating leases


10,073


9,123

Bad debt expense


2,071


1,355

Stock-based compensation


3,282


2,240

Deferred income taxes


2,479


(6,556)

Training equipment credits earned, net


47


(809)

Unrealized (loss) gain on interest rate swap


(664)


1,034

Other (gains) losses, net


(196)


112

Changes in assets and liabilities:





Receivables


(3,895)


3,777

Prepaid expenses


(898)


(79)

Other assets


2,709


(540)

Notes receivable


(579)


(159)

Accounts payable and accrued expenses


(16,446)


706

Deferred revenue


(9,554)


(17,481)

Operating lease liability


(10,745)


(8,566)

Other liabilities


(121)


(3,496)

Net cash (used in) provided by operating activities


(4,315)


10,400

Cash flows from investing activities:





Cash paid for acquisitions, net of cash acquired


(16,973)


(26,514)

Purchase of property and equipment


(38,641)


(53,149)

Proceeds from maturities of held-to-maturity securities


29,000


Return of capital contribution from unconsolidated affiliate



188

Net cash used in investing activities


(26,614)


(79,475)

Cash flows from financing activities:





Proceeds from revolving credit facility


90,000


Debt issuance costs related to the revolving credit facility


(484)


Payment of preferred stock cash dividend


(2,528)


(2,617)

Payments on term loans and finance leases


(715)


(678)

Payment of payroll taxes on stock-based compensation through shares withheld


(748)


(628)

Net cash provided by (used in) financing activities


85,525


(3,923)

Change in cash, cash equivalents and restricted cash


54,596


(72,998)

Cash and cash equivalents, beginning of period


66,452


133,721

Restricted cash, beginning of period


3,544


12,256

Cash, cash equivalents and restricted cash, beginning of period


69,996


145,977

Cash and cash equivalents, end of period


120,579


61,498

Restricted cash, end of period


4,013


11,481

Cash, cash equivalents and restricted cash, end of period


$              124,592


$                 72,979

 

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

SELECTED SUPPLEMENTAL FINANCIAL INFORMATION BY SEGMENT

(In thousands)

(Unaudited)


Financial Summary by Segment and Consolidated




Three Months Ended March 31, 2023



Three Months Ended March 31, 2022



UTI


Concorde


Corporate


Consolidated



UTI


Concorde


Corporate


Consolidated

Revenue


$ 107,560


$     56,260


$              —


$        163,820



$ 102,086


$             —


$              —


$        102,086

Total operating expenses


94,458


50,071


13,342


157,871



86,512



12,197


98,709

Net income


12,135


6,237


(14,892)


3,480



15,132



(7,778)


7,354









Six Months Ended March 31, 2023



Six Months Ended March 31, 2022



UTI


Concorde


Corporate


Consolidated



UTI


Concorde


Corporate


Consolidated

Revenue


$ 213,133


$     70,691


$              —


$        283,824



$ 207,161


$             —


$              —


$        207,161

Total operating expenses


183,516


65,228


24,683


273,427



168,420



21,786


190,206

Net income


27,960


5,503


(27,335)


6,128



38,091



(15,915)


22,176

 

Major Expense Categories by Segment and Consolidated



Three Months Ended March 31, 2023


UTI


Concorde


Corporate


Consolidated

Salaries, benefits and tax expense

$          46,065


$          26,503


$             5,164


$          77,732

Bonus expense

3,991


480


984


5,455

Stock-based compensation

644



1,469


2,113

Total compensation and related costs

$          50,700


$          26,983


$             7,617


$          85,300









Advertising expense

$          14,179


$            6,502


$                  —


$          20,681

Occupancy expense, net of subleases

8,071


5,946


158


14,175

Depreciation and amortization

5,096


1,649


3


6,748

Professional and contract services expense

2,918


175


3,051


6,144




Three Months Ended March 31, 2022


UTI


Concorde


Corporate


Consolidated

Salaries, benefits and tax expense

$          40,549


$                  —


$             4,412


$          44,961

Bonus expense

3,246



1,126


4,372

Stock-based compensation

205



1,404


1,609

Total compensation and related costs

$          44,000


$                  —


$             6,942


$          50,942









Advertising expense

$          14,469


$                  —


$                  —


$          14,469

Occupancy expense, net of subleases

9,674



173


9,847

Depreciation and amortization

3,869



15


3,884

Professional and contract services expense

1,947



3,918


5,865

 

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

SELECTED SUPPLEMENTAL FINANCIAL INFORMATION BY SEGMENT

(In thousands)

(Unaudited)


Major Expense Categories by Segment and Consolidated



Six Months Ended March 31, 2023


UTI


Concorde


Corporate


Consolidated

Salaries, benefits and tax expense

$          88,321


$           34,979


$           10,265


$        133,565

Bonus expense

7,534


668


2,118


10,320

Stock-based compensation

896



2,386


3,282

Total compensation and related costs

$          96,751


$           35,647


$           14,769


$        147,167









Advertising expense

$          27,528


$             7,782


$                   —


$          35,310

Occupancy expense, net of subleases

16,097


7,828


283


24,208

Depreciation and amortization

9,871


2,106


19


11,996

Professional and contract services expense

5,983


272


5,226


11,481




Six Months Ended March 31, 2022


UTI


Concorde


Corporate


Consolidated

Salaries, benefits and tax expense

$          78,468


$                  —


$             9,301


$          87,769

Bonus expense

6,753



2,112


8,865

Stock-based compensation

374



1,941


2,315

Total compensation and related costs

$          85,595


$                  —


$           13,354


$          98,949









Advertising expense

$          26,428


$                  —


$                   —


$          26,428

Occupancy expense, net of subleases

18,908



338


19,246

Depreciation and amortization

7,532



31


7,563

Professional and contract services expense

3,931



6,000


9,931

 

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

RECONCILIATION OF GAAP FINANCIAL INFORMATION TO NON-GAAP FINANCIAL INFORMATION

(In thousands)

(Unaudited)


Reconciliation of Net Income to EBITDA and Adjusted EBITDA



Three Months Ended March 31, 2023


UTI


Concorde


Corporate


Consolidated

Net income (loss)

$          12,135


$             6,237


$         (14,892)


$             3,480

Interest income

(4)


(128)


(1,673)


(1,805)

Interest expense

979


79


1,579


2,637

Income tax expense



1,763


1,763

Depreciation and amortization

5,094


1,649


3


6,746

EBITDA

18,204


7,837


(13,220)


12,821

Acquisition related costs



1,322


1,322

Integration related costs for acquisitions

97


374


543


1,014

Stock-based compensation expense

644



1,469


2,113

Start-up costs for new campuses and program expansion

1,751


170



1,921

Adjusted EBITDA, non-GAAP

$          20,696


$             8,381


$           (9,886)


$          19,191




Three Months Ended March 31, 2022


UTI


Concorde


Corporate


Consolidated

Net income (loss)

$          15,132


$                   —


$           (7,778)


$             7,354

Interest income

(1)



(7)


(8)

Interest expense

466




466

Income tax benefit



(4,598)


(4,598)

Depreciation and amortization

3,869



15


3,884

EBITDA

19,466



(12,368)


7,098

Acquisition related costs



2,023


2,023

Integration related costs for acquisitions

126




126

Stock-based compensation expense

205



1,404


1,609

Start-up costs for new campuses and program expansion

2,704




2,704

Facility lease accounting adjustments

(1,008)




(1,008)

Adjusted EBITDA, non-GAAP

$          21,493


$                   —


$           (8,941)


$          12,552

 

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

RECONCILIATION OF GAAP FINANCIAL INFORMATION TO NON-GAAP FINANCIAL INFORMATION

(In thousands)

(Unaudited)


Reconciliation of Net Income to EBITDA and Adjusted EBITDA



Six Months Ended March 31, 2023


UTI


Concorde


Corporate


Consolidated

Net income (loss)

$          27,960


$             5,503


$         (27,335)


$             6,128

Interest income

(7)


(164)


(2,457)


(2,628)

Interest expense

1,860


123


2,077


4,060

Income tax expense



3,288


3,288

Depreciation and amortization

9,869


2,106


19


11,994

EBITDA

39,682


7,568


(24,408)


22,842

Acquisition related costs



2,097


2,097

Integration related costs for acquisitions

316


524


1,269


2,109

Stock-based compensation expense

896



2,386


3,282

Start-up costs for new campuses and program expansion

3,075


225



3,300

Adjusted EBITDA, non-GAAP

$          43,969


$             8,317


$         (18,656)


$          33,630




Six Months Ended March 31, 2022


UTI


Concorde


Corporate


Consolidated

Net income

$          38,091


$                   —


$         (15,915)


$          22,176

Interest income

(5)



(15)


(20)

Interest expense

699




699

Income tax benefit



(5,945)


(5,945)

Depreciation and amortization

7,532



31


7,563

EBITDA

46,317



(21,844)


24,473

Acquisition related costs



2,909


2,909

Integration related costs for acquisitions

201




201

Stock-based compensation expense

374



1,941


2,315

Start-up costs for new campuses and program expansion

4,297




4,297

Facility lease accounting adjustments

(1,008)




(1,008)

Adjusted EBITDA, non-GAAP

$          50,181


$                   —


$         (16,994)


$          33,187

 

UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES

RECONCILIATION OF GAAP FINANCIAL INFORMATION TO NON-GAAP FINANCIAL INFORMATION

(In thousands)

(Unaudited)


Reconciliation of Net Income to Adjusted Net Income



Three Months Ended March 31,


Six Months Ended March 31,


2023


2022


2023


2022

Net income

$              3,480


$              7,354


$              6,128


$           22,176

Add back: Income tax expense (benefit)

1,763


(4,598)


3,288


(5,945)

     Income before income taxes

5,243


2,756


9,416


16,231

Adjustments:








  Acquisition related costs

1,322


2,023


2,097


2,909

Integration related costs for acquisitions

1,014


126


2,109


201

Start-up costs for new campuses and program expansion

1,921


2,704


3,300


4,297

Facility lease accounting adjustments


(1,008)



(1,008)

  Adjusted income before income taxes

9,500


6,601


16,922


22,630

Income tax effect: (expense) benefit

(3,192)


(238)


(5,263)


(815)

     Adjusted net income, non-GAAP

$              6,308


$              6,363


$           11,659


$           21,815









GAAP effective income tax rate (1)

33.6 %


3.6 %


31.1 %


3.6 %



(1)

The GAAP effective tax rate for the three and six months ended March 31, 2023 has been adjusted to remove the impact of the Concorde acquisition related costs. The GAAP effective tax rate for the three and six months ended March 31, 2022 has been adjusted to remove the impact from the MIAT purchase accounting adjustments for deferred tax liabilities and the reversal of the valuation allowance, both of which created a net tax benefit for the periods.

 

Reconciliation of Net Cash (Used in) Provided by Operating Activities to Adjusted Free Cash Flow



Six Months Ended March 31,


2023


2022

Net cash (used in) provided by operating activities, as reported

$                 (4,315)


$                 10,400

Purchase of property and equipment

(38,641)


(53,149)

  Free cash flow, non-GAAP

(42,956)


(42,749)

Adjustments:




Purchase of Lisle, Illinois campus


28,378

Purchase of Orlando, Florida campus

26,156


Acquisition related costs paid

1,367


1,872

Integration related costs paid

1,850


143

Cash outflow for start-up costs for new campuses and program expansion

3,300


2,987

Cash outflow for property and equipment for new campuses and program expansion

8,271


8,572

Facility lease accounting adjustments


575

Severance payment due to CEO transition


32

  Adjusted free cash flow, non-GAAP

$                 (2,012)


$                     (190)

 

SOURCE Universal Technical Institute, Inc.

Advertisement